1-((6-Methoxypyridin-3-yl)methyl)piperidin-3-amine dihydrochloride

Catalog No.: 
ACIFVT731
CAS No.: 
1185313-45-4
Molecular Formula: 
C12H21Cl2N3O
Molecular Weight: 
294.23
1-((6-Methoxypyridin-3-yl)methyl)piperidin-3-amine dihydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$186.00InquiryInquiry
1g95%$594.00InquiryInquiry
5g95%$2940.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-((6-Methoxypyridin-3-yl)methyl)piperidin-3-amine dihydrochloride
IUPAC Name1-((6-methoxypyridin-3-yl)methyl)piperidin-3-amine dihydrochloride
MDL No.MFCD09877723
Molecular FormulaC12H21Cl2N3O
Molecular Weight294.23
SMILESNC1CN(CC2=CC=C(OC)N=C2)CCC1.[H]Cl.[H]Cl
InChI KeyKKSSFRWEWRHEGV-UHFFFAOYSA-N
Synonym1-(6-Methoxy-pyridin-3-ylMethyl)-piperidin-3-ylaMine dihydrochloride, 98+% C12H21Cl2N3O, MW: 294.22;1-[(6-Methoxy-3-pyridinyl)methyl]-3-piperidinamine hydrochloride
CAS No.1185313-45-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACIFVT731 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACIFVT731 route product structure diagram
    ACIFVT7311185313-45-4
Inquiry

2. ACIFVT731 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACIFVT731 route product structure diagram
    ACIFVT7311185313-45-4
Inquiry

3. ACIFVT731 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACIFVT731 route product structure diagram
    ACIFVT7311185313-45-4
Inquiry

Comments (0)